Photodynamic therapy (PDT) was employed as a cancer therapy with photosensitizer (PS)-loaded cancer cells, eradicated by the reactive oxygen species after light activation. Cyclo-oxygenase 2 (COX2) is an enzyme expressed in 80% of colon adenocarcinoma and is one of the targets for effective cancer treatment. There is also uprising evidence that the human telomerase reverse transcriptase (hTERT), a catalytic component of telomerase, is reported as a promising indicator for monitoring cancer treatment.
INTRODUCTION
Photodynamic therapy (PDT) is a disease site-specific treatment modality. It involves the local or systemic administration of a photosensitizer followed by irradiating the targeted disease site with non-thermal visible light of appropriate wavelength(s). In the presence of molecular oxygen, the light illumination of photosensitizer and energy transfer can lead to a series of photochemical reactions and generation of reactive oxygen species, and consequently induce apoptosis and necrosis of targeted cells and tissues [1] [2] .
Mono-L-aspartylchlorin-e6 (NPe6) is one of the promising second-generation photosensitizers. NPe6 is a hydrophilic chlorine derived from chlorophyll a and has exhibited promise at in vitro and in vivo studies due to its excellent photosensitizing properties [3] [4] [5] [6] . NPe6-PDT has currently applied in advanced-stage clinical trials for cancer treatment due to its great depth-of-light penetration and rapid clearance rate in normal tissues [7] [8] [9] . However, there are still underlying mechanisms mediated by NPe6-PDT on cancer cells remain unknown.
Colon cancer is the third most prevalence cancer and the second leading cause of cancer related mortality worldwide [10] .
In Hong Kong, colon cancer is the second most common cancer type and the second death-leading cancer [11] . First line treatment for colon cancer is the combination of 5-fluorouracil based adjuvant chemotherapy with improved overall survival. Besides, different standard treatment approaches have been applied for colon cancer including surgery, radiotherapy and chemotherapy [12] . Surgery is the most common treatment for all stages of colon cancer; however, it is traumatic to patients. Both chemotherapy and radiotherapy are not cancer-selective causing side-effects. Therefore, PDT can be an alternative treatment modality for colon cancer.
Cyclo-oxygenase (COX) is an enzyme that catalyzes the oxidative conversion of arachidonic acid to prostaglandins, which take place in most tissues under both physiological and pathogenetic condition [13] . There are two isoforms of COX enzyme, COX1 and COX2. COX2 is commonly found in normal cells, such as endothelial cells, osteoblasts, fibroblasts, and macrophages [14] . It is also found that COX2 is over-expressed in about 80% of human colon cancers [13] .
Recent research suggested that the COX2 protein facilitates cancer cells growth, invasion and metastasis. Up-regulation of COX2 could promote angiogenesis by initiating cancer cell proliferation and inhibit apoptosis [15] . These implying that COX2 pathway could be the potential target for effective colon cancer treatment, thus inhibiting COX2 protein expression may induce apoptotic cell death in colon cancer cells.
Tumor therapies targeting telomerase represent an efficient way to specifically suppress tumor cell growth in telomerase over-expressed tumors. Studies have reported that applications of telomeres and telomerase can act as markers for cancer diagnosis and prognosis, especially through the measurements of the catalytic component of telomerase (hTERT -human telomerase reverse transcriptase) as a means of monitoring tumor response to therapy [16] . Several reports have revealed that hTERT could serve as a potential indicator for monitoring tumor treatments in medulloblastoma, uterine sarcoma, ovarian cancer and hepatoma tumor cells [17] [18] [19] [20] .
In this study, we aimed to investigate the efficacy of NPe6 mediated PDT on colon cancer cells (HT-29). The cell death mechanism, the modulation of COX2 expression and the regulation of hTERT mRNA expression by NPe6-PDT in HT-29 cells were evaluated by cell cycle progression, immuno-histochemical staining (IHC) and the relative quantitation of TaqMan real-time PCR respectively.
METHODOLOGY

Cell cultures and growth conditions
HT-29 was purchased from American Type Culture Collection (ATCC) is a human colon carcinoma cell line derived from colon epithelial cells obtained from a 44-years-old Caucasian female with colorectal adenocarcinoma. The cells were grown in RPMI 1640 medium supplemented with 10% fetal bovine serum (FBS) and 1% antibiotics PSN (50 IU/ml penicillin, 50 μg/ml streptomycin and 100 μg/ml neomycin) (Gibco TM Invitrogen Corporation, Carlsbad, CA, USA). The cells were incubated at 37.0ﾟC with 5% CO 2 .
Photosensitizer
Mono-L-aspartylchlorin-e6 (NPe6) was provided by Light Sciences Oncology in powder form. The stock solution (1mg/mL) was prepared by dissolving the powder in PBS and then diluted into appropriate concentrations for subsequent experiments and was stored at 4°C in dark. as described previously [21] . The phototoxicity was determined at 4 hours post-PDT using an automated cell viability analyzer -Vi-Cell TM (Beckman Coulter). Control cells without drug and light treatment and dark control (without light irradiation) were included. All results were presented as mean±S.D. from 4 independent experiments.
Uptake kinetic of NPe6 in HT-29 cells
Morphological changes of HT-29 cells after NPe6-PDT by microscopic examination
HT - 
NPe6-PDT modulated COX2 protein expression by immunohistochemical (IHC) staining
The COX2 protein expression on the HT-29 cells response to NPe6-PDT was demonstrated using COX2 antibody and Avidin Biotin Complex (ABC) Immunohistochemical (IHC) DAB staining (VECTOR ABC Elite Kit).
Diaminobenzidine tetrahydrochloride (DAB) acted as chromogen to localize peroxidase in cells as reddish brown precipitate. Briefly, the treated (LD 30 and LD 50 ), untreated and dark control cells were harvested at 4-hour-post-PDT.
Cells were re-suspended in 500 ul RPMI. The cell suspension were loaded and spin at 800rpm for 3 minutes, after disassemble the cassette, the slides were air dried, and fixed in cold methanol for 20 minutes at -20°C. All the procedures were followed as described by the manufacturer. Internal negative control was included using PBS instead of the primary COX2 antibody.
After the IHC staining, the slides were observed under light microscope (Nikon ECLIPSE 80i multiplied by the weighted intensity and the maximum value of H-score was 300 [22] [23] . All results were presented as mean±S.D. from 3 independent experiments.
Quantitation of hTERT mRNA expression mediated by NPe6-PDT using TaqMan real-time PCR
A more sensitive real-time PCR analysis to hTERT mRNA quantitation in HT-29 cells after NPe6-PDT was performed by pre-designed gene-specific primers and probe sets of TaqMan® Gene Expression Assay for hTERT and for GAPDH 
Data analysis
The GraphPad Prism Version 4.0 was used to analyze the results obtained. All data were presented as mean and standard error (S.D.). P value smaller than 0.05 (P < 0.05) was considered significant.
Uptake kinetics of NPe6 by HT-29 cells
The uptake of NPe6 was determined by the qantitation of the intracellular fluorescence intensity using flow cytometry, since the intracellular fluorescent intensity of NPe6 inside the HT-29 cells was directly proportional to the amount of NPe6 uptake by the cancer cells. From the results in Figure 1 , the uptake of NPe6 in HT-29 cells was found to be timeand drug-dosage dependent. Maximum uptake was obtained at 6 hours, while the fluorescence intensity reached maximal of 12 μg/mL, and remained in plateau with 16 μg/mL of NPe6. 
Phototoxicity of NPe6-PDT on HT-29 cells
Phototoxicity of NPe6-PDT on HT-29 cells was determined after 4 hours incubation time by the trypan blue exclusion assay using the Vi-Cell TM cell viability analyzer (Beckman Coulter, USA). Figure 2 showed the phototoxicity of HT-29 cells treated with NPe6-PDT at different concentrations (2, 4, 8, and 16 µg/ml), and different light doses (1 and 2 J/cm 2 ).
Dark control (without light treatment) and control (without both NPe6 and light treatment) were included. The results showed that the dark toxicity was negligible while significant phototoxicity was observed in NPe6-PDT treated cells in drug-and light-dosage dependent manners. Lethal doses were investigated that LD 30 was obtained with 8 µg/ml of NPe6 at 2 J/cm 2 ; while LD 50 was obtained at 16 µg/ml of NPe6 at 2 J/cm 2 , which were employed for subsequent experimental investigation. 
Microscopic Examination of Morphological Changes induced by NPe6-PDT in HT29cells
Cell shrinkage and membrane blebbing were the typical characteristics of apoptotic cells. The microscopic examination was employed to qualify any morphological changes of the cells after NPe6-PDT. At LD 30 4-hours post-PDT, over 30% cell shrinkage occurred; whereas at LD 50 4-hours post-PDT, there were over 60% of cells with typical membrane blebbing characteristics. The data indicated were from four individual experiments in triplicate. These results showed that NPe6-PDT induced apoptotic cell death in HT-29 cells (data not showed). For cell cycle analysis, percentage of HT-29 cells in S phase increased when the cells were treated at LD 30 and LD 50 24-hour-post-PDT (Table 1) . At LD 30 , the S-phase was shifted from 20.53% to 25.24%; while at LD 50, the S-phase was shifted from 20.53% to 35.20%. The percentage of cells in G0/G1 phase decreased at the same time. At LD 30 , the G0/G1 phase was shifted from 60.39% to 52.13%; while at LD 50, the G0/G1phase was shifted from 60.39% to 40.76%. The data indicated that the NPe6-PDT induced S-Phase arrest and decreased G0/G1 phase in HT-29 cells. 
Cell Cycle Analysis by Flow Cytometry
NPe6-PDT down-regulated COX2 protein expression in HT-29 cells
In the study, the COX2 protein expression modulated by NPe6-PDT on HT-29 cells was investigated by the IHC staining.
The images acquired and analyzed using H-Score systems. At LD 50 , the COX2 protein expression was significantly down-regulated by NPe6-PDT (One-way ANOVA, p<0.05) when compared with the control and dark control cells 
DISCUSSION
Studies have demonstrated that NPe6-PDT was effective for cutaneous tumor cell disruption in vitro and in vivo [6, 24] .
Due to the improved properties of NPe6, NPe6-PDT has also being applied clinically with promising results in skin and lung cancer patients [7, 25] . However, the detailed cell death mechanisms of NPe6-PDT in tumor cells remained to be explored.
Our study aims to elucidate the cell death mechanism induced by NPe6-PDT in a colon carcinoma cell line in vitro. In summary, this study reveals an effective and responsive PDT treatment of a colon carcinoma cell line (HT-29) with NPe6.
Encouraging evidence is shown in this study that NPe6-PDT not only acted as a COX2 inhibitor, but also downregulated the hTERT mRNA expression, which can be a marker for PDT monitoring. The HT-29 colon tumor cells were responsive to NPe6-PDT in the drug-and light-dose-dependent manner for the NPe6 uptake kinetics (Figure 1 ) and the NPe6-PDT mediated efficacy ( Figure 2 ). There is only negligible dark toxicity. It was reported that the effectiveness of NPe6 was related to plasma level and progressive uptake of NPe6 by the target cells could be obtained over several hours implying that high plasma concentrations of this photosensitizer were associated with toxicity [26] [27] . Therefore, the lower concentrations of NPe6 (8 µg/ml and 16 µg/ml) at 4 hours sensitization were recommended in the subsequent study to potentiate the effects of the drug on the proposed colon cells.
For the determination of cell death mechanism, our results revealed that there was 30% to 60% morphological cell From the results in Table 1 , apoptotic events could not be quantitated in the sub-G1 phase of the NPe6-PDT-treated cells thus apoptosis might not the dominant cell death mechanism mediated by NPe6-PDT in HT-29 cells. This result was in line with previous finding that NPe6, being a lysosomal photosensitizer, although, caused photodamage in murine tumor models but lack of a more substantial apoptotic response to PDT when lysosomes were the initial PDT target [28] [29] .
Therefore, NPe6-PDT modulated apoptotic protein expression related to lysosomes, such as caspase 3, could further be studied.
As over 80% of human colon tumors with COX2 over-expression, this study also evaluated the regulation of COX2 protein expression by NPe6-PDT in HT-29 cells [13] . Ferrario et al demonstrated that down-regulation of COX2 expression by PDT enhanced the efficacy of PDT in tumor killing [30] . In our study, there was a significant 4-fold down- This was similar to our previous findings that hexyl-ALA-PDT could also reduce the hTERT mRNA expression in both uterine sarcoma cell lines (>50% reduction) and medulloblastoma cell line (30% reduction) [17] [18] . The results suggested that hTERT mRNA expression could be a marker for monitoring NPe6-PDT in colon tumors in future clinical setting.
CONCLUSION
In conclusion, NPe6-PDT is effective for HT-29 colon cancer cells with its ability to induce phototoxicity to the cancer cells and causing cell cycle arrest in S-phase. Although, apoptosis was not the dominant cell death mechanism triggered by NPe6-PDT in HT-29 cells, the COX2 and hTERT mRNA expression were down-regulated by NPe6-PDT suggesting NPe6-PDT pave the way in future alternative treatment for colon cancers in clinical settings.
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